A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...

Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into ...

LDL cholesterol is an important marker, but others such as ApoB, hs-CRP, and insulin resistance should not be ignored, shares ...

My goal in this letter is to begin to reconcile one of the most divisive and important debates in healthcare and nutrition today: the role of cholesterol in heart disease.

A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a ...

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...

New REDUCE-IT data presented at EAS 2026 suggests risk-weighted apoB could better identify residual cardiovascular risk in statin-treated patients with elevated triglycerides. Key Investor ...

Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the foundational therapy for patients with MASH ...

Every day, your liver assembles billions of tiny cholesterol-carrying particles and ships them into your blood. How many it ...

Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...

LIB Therapeutics Inc. (LIB), a privately-held, biopharmaceutical company with a recently approved novel, monthly, small-dose, third-gene ...